Progenics Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Progenics Pharmaceuticals ( PGNX) is a biopharmaceutical company focusing on the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. The stock is trading up 5.8% at $10.40 in recent trading.

Today's Volume: 100,000

Average Volume: 113,794

Volume % Change: 100%

>>5 Stocks to Trade for Breakout Gains

From a technical perspective, PGNX is ripping higher today on decent volume, and this stock is flirting with a major breakout trade. That trade will hit once PGNX takes out its 52-week high of $10.50 with high-volume. Keep in mind that the last time PGNX traded above $11 a share is back in 2008.

Traders should now look for long-biased trades in PGNX if it can sustain a move or close above $10.50 with volume that's near or well above 113,794 shares. If we get that action today or soon, then PGNX could start a bigger trend toward $15.

If you liked this article you might like

How to Trade Monday's Most Active Stocks -- Rite Aid, BofA, Fitbit, More

Keysight Technologies to Grab Ixia for $1.6 Billion

Cisco Investors Watch Earnings for Look Into the IT Market, Trump's Tech Effect

Here's Why Ixia (XXIA) Stock Is Tanking Today

Insider Trading Alert - DXYN, XXIA And NTWK Traded By Insiders